000 03826naa a22005417i 4500
001 UMUN-OA-20261005-MLS-063
003 local
005 20261005174906.0
006 m o d
007 cr||||||||||||
008 261005s2018 xx o u000 0 eng d
024 7 _a10.1093/ajcp/aqx147
_2doi
035 _a(local)EuropePMC:PMC6016712
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aMatthew Rubinstein
_eauthor.
245 1 0 _aEffectiveness of Practices to Support Appropriate Laboratory Test Utilization: A Laboratory Medicine Best Practices Systematic Review and Meta-Analysis. /
_cMatthew Rubinstein; Robert Hirsch; Kakali Bandyopadhyay [and others].
264 1 _a[Place of publication not identified] :
_bOxford University Press,
_c2018.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aObjectives To evaluate the effectiveness of practices used to support appropriate clinical laboratory test utilization. Methods This review followed the Centers for Disease Control and Prevention (CDC) Laboratory Medicine Best Practices A6 cycle method. Eligible studies assessed one of the following practices for effect on outcomes relating to over- or underutilization: computerized provider order entry (CPOE), clinical decision support systems/tools (CDSS/CDST), education, feedback, test review, reflex testing, laboratory test utilization (LTU) teams, and any combination of these practices. Eligible outcomes included intermediate, systems outcomes (eg, number of tests ordered/performed and cost of tests), as well as patient-related outcomes (eg, length of hospital stay, readmission rates, morbidity, and mortality). Results Eighty-three studies met inclusion criteria. Fifty-one of these studies could be meta-analyzed. Strength of evidence ratings for each practice ranged from high to insufficient. Conclusion Practice recommendations are made for CPOE (specifically, modifications to existing CPOE), reflex testing, and combined practices. No recommendation for or against could be made for CDSS/CDST, education, feedback, test review, and LTU. Findings from this review serve to inform guidance for future studies.
540 _aCreative Commons Attribution-NonCommercial. See the linked licence for the applicable terms.
_uhttp://creativecommons.org/licenses/by-nc/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _aclinical chemistry
655 4 _aReview articles.
700 0 _aRobert Hirsch
_eauthor.
700 0 _aKakali Bandyopadhyay
_eauthor.
700 0 _aBereneice Madison
_eauthor.
700 0 _aThomas Taylor
_eauthor.
700 0 _aAnne Ranne
_eauthor.
700 0 _aMillie Linville
_eauthor.
700 0 _aKeri Donaldson
_eauthor.
700 0 _aFelicitas Lacbawan
_eauthor.
700 0 _aNancy Cornish
_eauthor.
773 0 _tAmerican journal of clinical pathology
_gVol. 149, no. 3, (2018), pages/article 197-221
_x0002-9173
856 4 0 _uhttps://europepmc.org/articles/PMC6016712
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC6016712
_qlocal
942 _n0
999 _c1205
_d1205